💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Epizyme, Inc. (EPZM)
« Back to company indexEPZM Chatter Timeline
Stock Ticker for EPZM
Most Active Tweeters for EPZM
| User | Tweets |
|---|---|
| @forney_kirk | 5 |
| @PennySearch | 5 |
| @Tickeron | 4 |
| @22_vkb | 2 |
| @TradeWithAlerts | 2 |
Recent Tweets for EPZM
 |
@PennySearch $EPZM Morgan Stanley gave EPZM a Underweight stock rating on 2021-08-10. Find top penny stocks with PennySearch… https://t.co/VyZgkEa9nd January 24th 2022, 2:01am |
|
@PennySearch $EPZM Morgan Stanley gave EPZM a Underweight stock rating on 2021-08-10. Find top penny stocks with PennySearch… https://t.co/ekSrKiRhdv January 23rd 2022, 10:01am |
 |
@Tickeron $EPZM in -5.91% Downtrend, sliding for three consecutive days on January 18, 2022. View odds for this and other ind… https://t.co/TlZ3QSXPUx January 22nd 2022, 9:01pm |
|
@PennySearch $EPZM Morgan Stanley gave EPZM a Underweight stock rating on 2021-08-10. Find top penny stocks with PennySearch… https://t.co/YnWgRGg18g January 21st 2022, 6:01am |
 |
@TradeWithAlerts Nice print for $EPZM Size: 104782 Price: 2.19 Amount: $229,472.58 Time: 1600 See more: https://t.co/AAxtMlHR3d Join… https://t.co/0kuxadTbhA January 20th 2022, 9:01pm |
 |
@GetOnTrade $EPZM Epizyme Granted FDA Orphan Designation For Treatment Of Multiple Myeloma https://t.co/ctBzss51JY January 20th 2022, 5:01pm |
 |
@forney_kirk RT @22_vkb: Adding $EPZM at $2.08 on news. Let’s see if they send it January 20th 2022, 3:01pm |
|
@forney_kirk RT @newsinthemarket: Epizyme granted orphan status for multiple myeloma treatment $EPZM January 20th 2022, 3:01pm |
|
@forney_kirk RT @3Stocksaday: $EPZM SHOULD START A RUN FOR FEW DAYS... $3-4 with patience January 20th 2022, 3:01pm |
|
@forney_kirk RT @22_vkb: $EPZM sold for breakeven will revisit January 20th 2022, 3:01pm |
|
@forney_kirk RT @3Stocksaday: $EPZM $3-4 with patience...! ?? https://t.co/e8uStN9DjC January 20th 2022, 3:01pm |
 |
@3Stocksaday $EPZM $3-4 with patience...! ?? https://t.co/e8uStN9DjC January 20th 2022, 3:01pm |
 |
@22_vkb $EPZM sold for breakeven will revisit https://t.co/CiOy7Qt44w January 20th 2022, 2:01pm |
|
@Tickeron This is amazing! What do you think? $EPZM RSI Indicator left the oversold zone. #Epizyme #stockmarket #stock… https://t.co/pxkzdiFGz2 January 20th 2022, 9:01am |
|
@3Stocksaday $EPZM SHOULD START A RUN FOR FEW DAYS... $3-4 with patience January 19th 2022, 6:01pm |
 |
@MarketCurrents $EPZM - Epizyme multiple myeloma candidate granted FDA Orphan Drug Designation https://t.co/yAp8gB82ZY January 19th 2022, 5:01pm |
 |
@vtmtrading Epizyme granted orphan status for multiple myeloma treatment $EPZM January 19th 2022, 5:01pm |
|
@22_vkb Adding $EPZM at $2.08 on news. Let’s see if they send it January 19th 2022, 4:01pm |
 |
@MarketNFlash Epizyme Granted FDA Orphan Designation For Treatment Of Multiple Myeloma | $EPZM https://t.co/CzDY0W2upb January 19th 2022, 4:01pm |
|
@PennySearch $EPZM Morgan Stanley gave EPZM a Underweight stock rating on 2021-08-10. Find top penny stocks with PennySearch… https://t.co/232n284ekz January 16th 2022, 11:01am |
 |
@ShogunTrade $EPZM Awaiting Buy Signal. Free 7 Day Trial at https://t.co/6vnULU2sSf https://t.co/9VlbLKmL6O January 15th 2022, 8:01pm |
 |
@kwhenfinance Epizyme Inc Shares Near 52-Week Low - Market Mover https://t.co/dnqjvo49Yj $EPZM #stockmarket #kwhenfinance January 15th 2022, 8:01am |
 |
@StckPro $EPZM NEW ARTICLE : Epizyme (EPZM) Receives a Buy from Barclays https://t.co/skrml1jOzl Get all the latest $EPZM re… https://t.co/duDBcetZdb January 15th 2022, 2:01am |
|
@Tickeron $EPZM in -10.2% Downtrend, falling for three consecutive days on January 13, 2022. View odds for this and other ind… https://t.co/XZlhB7au7X January 14th 2022, 9:01pm |
|
@TradeWithAlerts Nice print for $EPZM Size: 195281 Price: 2.17 Amount: $423,759.77 Time: 1600 See more: https://t.co/AAxtMlHR3d Join… https://t.co/Q2RBkJ6MjP January 14th 2022, 9:01pm |
|
@Tickeron Does this make you nervous? $EPZM Stochastic Oscillator left the oversold zone. #Epizyme #stockmarket #stock… https://t.co/SymHhKcL4I January 14th 2022, 8:01pm |
 |
@A1Syad $EPZM Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/1oWnZ6HLDN January 14th 2022, 1:01pm |
 |
@SismasStock $EPZM waiting for Buy signal on EPZM with https://t.co/WNHrn471Z1 https://t.co/V1lVdjFozF January 13th 2022, 2:01pm |
|
@PennySearch $EPZM Morgan Stanley gave EPZM a Underweight stock rating on 2021-08-10. Find top penny stocks with PennySearch… https://t.co/fGP38XsVRb January 13th 2022, 5:01am |
 |
@MaiteMerenda $EPZM Awaiting Short Signal. Free trial at https://t.co/t5kOjgsWN3 https://t.co/eyrjCqViP7 January 12th 2022, 4:01pm |
 |
@stock_patterns $EPZM - Pattern Detected ? Green line shows the recent price movements Red lines shows the similar price movements https://t.co/CiGV13mJkt January 12th 2022, 2:01pm |
|
@A1Syad $EPZM Awaiting Short Signal. Stock Trading Ideas by https://t.co/1MjnDHV7ua https://t.co/BiRwH315Fd January 12th 2022, 2:01pm |
 |
@OptionHunt Ticker $EPZM Unusual Volume Detected: 30.06% over average January 11th 2022, 5:01pm |
|
@Tickeron If you’re trading this week, Read This! $EPZM RSI Indicator left the oversold zone. #Epizyme #stockmarket #stock… https://t.co/LaaApx7hPE January 11th 2022, 4:01pm |
 |
@Uncletrade1 $EPZM Waiting for Short signal on EPZM with https://t.co/a56bsndwqN https://t.co/boebfxPAq8 January 11th 2022, 2:01pm |
 |
@ShortAlgoKing $EPZM Awaiting Short Signal. Chart by https://t.co/qchl9O5K2n https://t.co/Wz5lQ7z8db January 11th 2022, 12:01pm |
|
@A1Syad $EPZM Awaiting Short Signal Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/hJXh3KlAgO January 11th 2022, 1:01am |
 |
@equity_newswire $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical T… https://t.co/pMHhelIyiL January 10th 2022, 7:01pm |
 |
@KmaxtremeKr $EPZM not ? growth, but nice to see they’re progressing. As always - slowly but surely. Curious how they gonna deal with financing in 2022… January 10th 2022, 6:01pm |
|
@GetOnTrade $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical T… https://t.co/NMQP8iztYQ January 10th 2022, 6:01pm |
|
@KmaxtremeKr RT @EpizymeRx: Today $EPZM provided business highlights, preliminary fourth quarter and full year 2021 financials and clinical trial update… January 10th 2022, 6:01pm |
 |
@Gambiste1 RT @HouTxbestArtist: $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Tria… January 10th 2022, 5:01pm |
 |
@HouTxbestArtist $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates January 10th 2022, 5:01pm |
 |
@mehabecapital $EPZM @ 2.39 (+6.00%) : Epizyme jumps after product revenue shows strong sequential growth: Q4 Prelim https://t.co/SqbsdeXduw January 10th 2022, 5:01pm |
|
@StckPro $EPZM NEW ARTICLE : Epizyme jumps after product revenue shows strong sequential growth: Q4 Prelim… https://t.co/jTcKEVg9Oh January 10th 2022, 4:01pm |
|
@MarketCurrents $EPZM - Epizyme jumps after product revenue shows strong sequential growth: Q4 Prelim https://t.co/P6XNE0kI6o January 10th 2022, 4:01pm |
 |
@gcassidy718 $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical T… https://t.co/AEq01lFjIr January 10th 2022, 4:01pm |
 |
@MarcJacksonLA $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical T… https://t.co/l69nY2H7ee January 10th 2022, 3:01pm |
 |
@blue_pr_news $EPZM Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical T… https://t.co/CU8cH3ztr8 January 10th 2022, 2:01pm |
 |
@FlashAlert_me $EPZM [15s. delayed] filed form 8-K on January 10, 07:05:32 https://t.co/yTL8oR3SUk January 10th 2022, 12:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?